Forecast Of The Day: American Express Consumer Card Provisions As % of Loan Portfolio

AXP: American Express Company logo
American Express Company


American Express (NYSE:AXP) continues to see consumer card delinquency rates – which refers to the fraction of customers who have fallen behind on required monthly payments – improve in the month of April. U.S. consumer card delinquency rate improved to 0.8%, from 0.9% in March and 1.7% in April 2020. The net write-off rate also declined from 1.1% in March and 2.7% in April 2020 to 1.0%.


Relevant Articles
  1. American Express Stock Is Up 17% YTD, What To Expect From Q1?
  2. Up 21% YTD, Where Is American Express Stock Headed?
  3. Up 25% YTD, What To Expect From American Express Stock?
  4. American Express Stock To Beat The Expectations In Q3
  5. What To Expect From American Express Stock?
  6. American Express Stock To Top The Consensus In Q2

The economy is opening up post the Covid-19 related lockdowns and consumers are also benefiting from the federal government’s stimulus checks. This means that fewer people are delaying their credit card payments.

So What?

The improving credit environment should mean that AmEx will need to set aside less cash to cover future potential losses, potentially helping profitability. That said, AmEx is less dependent on credit card loans versus peers, as a bulk of the company’s revenue comes from discount fees, which are the fees charged to merchants for transactions AmEx cardholders make.

See Our Complete Analysis For American Express

Looking for a balanced portfolio to invest in? Here’s a high-quality portfolio to beat the market, with over 150% return since 2016, versus 85% for the S&P 500. Comprised of companies with strong revenue growth, healthy profits, lots of cash, and low risk, it has outperformed the broader market year after year, consistently.

See all Trefis Price Estimates and Download Trefis Data here

What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams | Product, R&D, and Marketing Teams